# Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells

> **NCT07199569** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Bavarian Nordic** · enrollment: 970 (actual)

## Conditions studied

- Monkeypox (Mpox)

## Interventions

- **BIOLOGICAL:** Jynneos
- **BIOLOGICAL:** MVA-BN (Quail)

## Key facts

- **NCT ID:** NCT07199569
- **Lead sponsor:** Bavarian Nordic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-27
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 970 (ACTUAL)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07199569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07199569, "Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07199569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*